š° Including Stroke News
Page 2 - Including Stroke News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Including Stroke. Real-time updates on events, politics, business and more.
October 29, 2021
Press release content from PR Newswire. The AP news staff was not involved in its creation.
October 28, 2021
Investegate announcements from Indivior PLC, 3rd Quarter Results
June 1, 2021
-- New Oral Medication Offers Established Antipsychotic Efficacy of Olanzapine With Less Weight Gain -- -- Commercial Launch Planned for Fourth Quarter 2021 -- -- Company to Host Investor
June 1, 2021
/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced that the U.S. Food and Drug Administration (FDA) has approved LYBALVIā¢ (olanzapine and samidorphan)...
May 4, 2021
Alkermes to Showcase Data From Psychiatry Portfolio at Upcoming Scientific Conferences Throughout Mental Health Awareness Month New Outcomes Research in Patients With Schizophrenia or Bipolar I Disorder to be Presented Published 05-04-21 Submitted by Alkermes DUBLIN,Ā May 4, 2021Ā /CSRwire/Ā --Ā Alkermes plcĀ (Nasdaq: ALKS) recently announced plans to present clinical data and outcomes research from its psychiatry portfolio at three scientific conferences during Mental Health Awareness Month in...
April 29, 2021
5 - * Adjusted (Adj.) basis excludes the impact of exceptional items as referenced in Notes 3 and 4. Comment by Mark Crossley, CEO of Indivior PLC "We have seen an encouraging start in FY 2021 with growth in net revenue, operating profit and cash from execution against our strategic priorities. Despite the ongoing impacts of COVID-19, SUBLOCADEĀ® (buprenorphine extended-release) injection achieved solid net revenue growth both on a sequen...
April 20, 2021
Alkermes Presents New Data From Psychiatry Portfolio at Virtual 2021 Congress of the Schizophrenia International Research Society - New Exploratory Analyses Presented From ENLIGHTEN-2 Study of LYBALVIā¢ in Patients With Schizophrenia - News provided by Share this article Share this article DUBLIN, April 20, 2021 /PRNewswire/ --Ā Alkermes plcĀ (Nasdaq: ALKS) today announced the presentation of new research from its psychiatry portfolio at the 2021Ā Congress of the Schizophrenia International Re...